97 related articles for article (PubMed ID: 18426663)
1. [Effects of IL-21 alone or in combination with IL-15/IL-2 on proliferation and anti-tumor activity of G-CSF-mobilized peripheral blood mononuclear cells in vitro].
Li L; Liu TQ; Liu ZQ; Liu GX; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):350-4. PubMed ID: 18426663
[TBL] [Abstract][Full Text] [Related]
2. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources].
Zhai WH; Huang Y; Wang M; Zhou Z; Zhai WJ; Zhang RL; Zhang P; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):633-6. PubMed ID: 19549378
[TBL] [Abstract][Full Text] [Related]
3. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin 21 and/or interleukin 12 on the antitumor activity of peripheral blood mononuclear cells in patients with endometrial cancer.
Tian YJ; Cui BX; Ma DX; Zhang Y; Hou F; Zhang WJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):292-8. PubMed ID: 21718613
[TBL] [Abstract][Full Text] [Related]
5. [Effects of mobilization with medium dose of rhG-CSF on the immunocyte component of peripheral blood in donors].
Huang WR; Da WM; Deng XL; Gao CJ; Han XP; Wu XX; Li HH; Zhu HY; Jin HJ; Jing Y; Wang SH; Bo J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):852-6. PubMed ID: 16277857
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy.
Meehan KR; Wu A; Hassan R; Miao Y; Chawla J; Slack R; Gehan E; Herscowitz HB
J Hematother Stem Cell Res; 2001 Apr; 10(2):283-90. PubMed ID: 11359675
[TBL] [Abstract][Full Text] [Related]
7. [Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite].
Yang L; Liu FQ; Wang JW; Wu YP; Ding J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):892-7. PubMed ID: 18718085
[TBL] [Abstract][Full Text] [Related]
8. [The Antitumor Activity of G-CSF-Mobilized Peripheral Blood Mononuclear Cells Activated by IL-2 Alone or in Combination with IL-12].
Sun WJ; Guo ZK; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Dec; 9(4):333-337. PubMed ID: 12578574
[TBL] [Abstract][Full Text] [Related]
9. [Activation ability of CpG ODNs 2216 on PBMNCs from leukemia patients in remission and killing effect of activated PBMNCs on K562 cells].
Gu YY; Chen JH; Ouyang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):874-8. PubMed ID: 19698220
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells.
Li S; Zhou B; Han ZC
Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493
[TBL] [Abstract][Full Text] [Related]
11. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro].
Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405
[TBL] [Abstract][Full Text] [Related]
12. [Effect of various combinations of IL2, IL12 and IL15 on function of human peripheral blood derived NK cells].
Li XH; Ma J; Wu XX; Li M; Wang FF; DA WM; Yu L; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):918-23. PubMed ID: 19698229
[TBL] [Abstract][Full Text] [Related]
13. [Ex vivo expansion of highly purified NK cells from human peripheral blood].
Li XH; Ma J; Wang FF; Dou LP; Li M; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):373-7. PubMed ID: 17493350
[TBL] [Abstract][Full Text] [Related]
14. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS
In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony stimulation factor (G-CSF) suppresses interleukin (IL)-12 and/or IL-2 induced interferon (IFN)-gamma production and cytotoxicity of decidual mononuclear cells.
Sugita K; Hayakawa S; Karasaki-Suzuki M; Hagiwara H; Chishima F; Aleemuzaman S; Li JA; Nishinarita S; Yamamoto T
Am J Reprod Immunol; 2003 Jul; 50(1):83-9. PubMed ID: 14506932
[TBL] [Abstract][Full Text] [Related]
16. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
[TBL] [Abstract][Full Text] [Related]
17. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.
Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B
Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625
[TBL] [Abstract][Full Text] [Related]
18. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
[TBL] [Abstract][Full Text] [Related]
19. [Impact of mobilization with rhG-CSF on the proliferation and cytotoxicity of donor's T cells].
Huang WR; Wang LS; Gao CJ; Lu ZZ; Wang H; Duan HF; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):995-8. PubMed ID: 17096905
[TBL] [Abstract][Full Text] [Related]
20. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
